Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal

Al­ny­lam Phar­ma­ceu­ti­cals an­nounced its first dis­cov­ery-fo­cused AI deal Wednes­day, tap­ping a Sil­i­con Val­ley biotech start­up to see if AI can boost its R&D ef­forts.

Al­ny­lam …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.